Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
Status:
Completed
Trial end date:
2012-06-26
Target enrollment:
Participant gender:
Summary
The main purpose of this study is the evaluation of concomitant association of
ultrafractionated irradiation and Temodal® in patients with inoperable primary glioblastoma
multiforme; study of tolerance and objective response rate.
The secondary purposes of this study are the evaluation of progression free survival, global
survival and tolerance through toxicity study. The therapeutic response according to
methylation or not of MGMT is also evaluated.